Feinstein Institutes Wins $3.37M Grant to Boost First-Responder Mental Health
MANHASSET, N.Y. — November 27, 2025: Feinstein Institutes for Medical Research, in collaboration with Stony Brook University and Texas...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
MANHASSET, N.Y. — November 27, 2025: Feinstein Institutes for Medical Research, in collaboration with Stony Brook University and Texas...
YONGIN, South Korea — November 27, 2025: GC Genome has announced the publication of its landmark study on a...
